Samsara BioCapital, LLC
Samsara BioCapital, LLC reported 27 positions worth $1.05B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: SRRK (31.7%). Biggest move: new buy PMVP ($12.1M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | SRRK | $333.3M | 31.69% | 6,897,652 | — | — | -7.8% | |
| ▸ 2 | MLYS | $147.5M | 14.03% | 5,871,018 | — | — | -39.0% | |
| ▸ 3 | SEPN | $120.0M | 11.41% | 3,066,453 | — | — | +6.5% | |
| ▸ 4 | ALMR | $84.5M | 8.04% | 2,480,310 | — | — | -10.3% | |
| ▸ 5 | SGP | $54.9M | 5.22% | 2,109,953 | — | — | — | |
| ▸ 6 | ALMS | $53.5M | 5.08% | 7,235,809 | — | — | -30.4% | |
| ▸ 7 | NGNE | $51.9M | 4.94% | 1,867,127 | — | — | -14.0% | |
| ▸ 8 | KLRS | $37.2M | 3.54% | 12,881,175 | — | — | — | |
| ▸ 9 | IVA | $23.3M | 2.22% | 6,314,805 | — | — | — | |
| ▸ 10 | PBLS | $18.0M | 1.71% | 556,044 | — | — | -13.8% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Samsara BioCapital, LLC hold as of Q3 2026?
Samsara BioCapital, LLC reported 27 positions worth $1.05B in its Q3 2026 13F filing. Largest positions: SRRK (31.7%), MLYS (14.0%), SEPN (11.4%), ALMR (8.0%) and SGP (5.2%).
What did Samsara BioCapital, LLC buy in Q3 2026?
New positions: PMVP, OBX, TCGX ACQUISITION CORP and GOSSAMER BIO INC . Added to: ALMS, NGNE and VTVT.
What did Samsara BioCapital, LLC sell in Q3 2026?
Reduced: SEPN, AQST, UPB, XFOR and AGMB (6 in all). Sold out entirely: GOSS.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.